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Abstract 28 
The SARS-CoV-2 has spread throughout the world since its discovery in 29 
China, and Malaysia is no exception. WGS has been a crucial approach in studying 30 
the evolution and genetic diversity of SARS-CoV-2 in the ongoing pandemic, and 31 
while an exceptional number of SARS-CoV-2 complete genomes have since been 32 
submitted to GISAID and NCBI, there is a scarcity of data from Malaysia. This study 33 
aims to report new Malaysian lineages responsible for the sustained spikes in 34 
COVID-19 cases during the third wave of the pandemic. Patients whose 35 
nasopharyngeal and oropharyngeal swabs were confirmed positive by real-time RT-36 
PCR with Ct-value < 25 were chosen for WGS. The 10 SARS-CoV-2 isolates 37 
obtained were then sequenced, characterized and analyzed, including 1356 38 
sequences of the dominant lineages of D614G variant currently circulating 39 
throughout Malaysia. The prevalence of clade GH and G formed strong ground of 40 
the discovery of two Malaysian lineages that caused sustained spikes of cases 41 
locally. Statistical analysis on the association of gender and age group with 42 
Malaysian lineages revealed a significant association (p < 0.05). Phylogenetic 43 
analysis revealed dispersion of 41 lineages, for which 22 lineages are still active. 44 
Mutational analysis observed unique G1223C missense mutation in Transmembrane 45 
Domain of Spike protein. Thus, calls for the large-scale WGS analysis of strains 46 
found around the world for greater understanding of viral evolution and genetic 47 
diversity especially in addressing the question of the effect of deleterious substitution 48 
mutation in transmembrane region of Spike protein. 49 
 50 
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The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-57 
CoV-2) also known as COVID-19 in Wuhan, China in December 2019  resulted in an 58 
unprecedented  global outbreak and has now become  a major public health issue 59 
[1–4]. To date, more than 190,671,330 confirmed cases of COVID-19, including 60 
4,098,758 deaths have been reported to the World Health Organization (WHO) 61 
worldwide [5]. By the same date, the cumulative number of confirmed cases of 62 
COVID-19 in Malaysia had reached 939,899, of which 7,241 died from the disease 63 
while 798,955 survived. The daily number of confirmed cases of COVID-19 has 64 
continued to soar with more than 10,000 cases per day since July 13, 2021 [6]. 65 
Malaysia is facing a much tougher task in curbing the COVID-19 pandemic in its third 66 
wave due to the emergence of outbreaks in Sabah [7]. Since then, the highest 67 
lineage contributor during the third wave of pandemic as B.1.524, with Glycine at 68 
residue 614 (G614) of the Spike protein, replacing Aspartic acid (D614) and Valine at 69 
residue 701 (V701) of the Spike protein, replacing Alanine (A701) [8].  70 
The WHO defined  SARS-CoV-2 Variant of Concerns (VOCs) as variants with 71 
clear evidence indicating significant impact in higher transmissibility, severity 72 
(including hospitalizations or death) and/or immunity due to significant reduction in 73 
neutralization by antibodies generated during previous infection or vaccination, as 74 
well as reduced effectiveness of treatments or vaccines that is likely to have an 75 
impact on the epidemiological situation [9,10]. Whereas Variant of Interests (VOIs) 76 
are variants with specific genetic markers that have been associated with changes to 77 
receptor binding, reduced neutralization by antibodies generated against previous 78 
infection or vaccination, reduced efficacy of treatments, potential diagnostic impact, 79 
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or predicted increase in transmissibility or disease severity [11]. The SARS-CoV-2 80 
VOCs UK B.1.1.7 (Alpha) was first detected in Malaysia since February followed by 81 
VOIs Nigerian B.1.525 (Eta) on March, and VOCs South African B.1.351 (Beta) on 82 
March this year. VOCs Indian B.1.617.2 (Delta) were detected from June in 83 
Peninsular Malaysia, followed by VOIs B.1.617.1 (Kappa) from June this year [12]. In 84 
Sarawak, the first Delta variant was detected on June, together with VOIs Philippines 85 
P.3 (Theta) in 2021[13].  86 
Of interest, all of the VOCs and VOIs detected in Malaysia share a D614G 87 
mutation in their Spike protein [14,15]. Until recently, 90.30% of all COVID-19 88 
infection in Malaysia has been due to the D614G variant, and this mutation remains 89 
in all new emerging variants [14]. As a result of positive natural selection, it was 90 
found that D614G increases the infectivity, viral fitness, transmission rate and 91 
efficiency of cellular entry for the SARS-CoV-2 virus across a broad range of human 92 
cell types [8,16–22]. Nevertheless, D614G mutation alone has not been shown to 93 
cause higher COVID-19 mortality or clinical severity, or alter the efficiency of the 94 
current laboratory diagnostic, therapeutics, vaccines or public health prevention 95 
strategies [10,23]. Therefore, in this study, we analyzed the dominant lineages of 96 
D614G variants currently circulating in Malaysia using whole complete genome of 97 
the Malaysian SARS-CoV-2 deposited to the Global Initiative on Sharing All 98 
Influenza Data (GISAID) database. This study aims to report new Malaysian lineages 99 
that are responsible in causing sustained spikes in COVID-19 cases throughout the 100 
third wave of the pandemic in Malaysia. We also investigated the divergency of the 101 
D614G variant of the Pahang SARS-CoV-2 virus isolates and its possible origin. 102 
Here we report the list of amino acid mutations in Spike protein detected in Pahang 103 
SARS-CoV-2 strains and hence predict the changes in protein-protein binding affinity 104 
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due to these missense amino acid mutations. Finally, we computationally predict a 105 
possible effect on the biological function of a Spike protein due to occurrence of a 106 
unique mutation of G1223C in Transmembrane (TM) Domain of Spike protein which 107 
only detected in Pahang SARS-CoV-2.  108 
 109 
Materials and Methods 110 
. 111 
Sample selection 112 
 113 
Nasopharyngeal and oropharyngeal swab test results from 10 patients that 114 
were confirmed positive for SARS-CoV-2 through real-time reverse transcriptase-115 
PCR (real-time RT-PCR) at the local hospital was selected for whole genome 116 
sequencing.  117 
 118 
RNAs extraction  119 
 120 
Samples were selected based on real-time RT PCR quality data where the 121 
RNAs must be more than 10ng/ul and have low cycle threshold. The RNA was 122 
extracted before real-time reverse transcriptase (RT-PCR) techniques to identify 123 
SARS-CoV-2. The genome information was then uploaded to international 124 
databases such as NCBI and GISAID.  125 
Next-generation sequencing of the full-length viral genome 126 
 127 
A next-generation sequencing (NGS) library was constructed after amplifying 128 
the isolates’ full-length genes using synthesized cDNA from SuperScriptIV 129 
(ThermoFisher Scientific, USA) with some modifications [24,25]. Briefly, 5 µl of the 130 
cDNA was used as template for multiplex PCR using Q5 polymerase (NEB, USA) as 131 
well as the Artic v3 primer pools during library preparation. The constructed library 132 
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was sequenced on an iSeq 100 System (Illumina, USA) (with run configuration of 133 
1 × 300 bp). 134 
 135 
Sequence analysis 136 
 137 
The SARS-CoV-2 genome was reconstructed from the raw reads using a 138 
combination of bioinformatic tools as listed in https://github.com/CDCgov/SARS-139 
CoV-2_Sequencing/tree/master/protocols/BFX-UT_ARTIC_Illumina. Genome 140 
sequences from other studies related to human and animal coronavirus were mined 141 
from the GISAID (https://www.gisaid.org) and NCBI GenBank 142 
(https://www.ncbi.nlm.nih.gov/genbank/). 143 
 144 
Public database SARS-CoV-2 genome analysis  145 
 146 
For the study of dominant lineage and D614G frequency, a total of 1356 147 
whole or complete genome sequences of Malaysian SARS-CoV-2 Malaysia that 148 
were submitted to GISAID were retrieved from March 1, 2020 to July 19, 2021. 149 
Analysis of lineage distribution and clade frequency were performed manually by 150 
using Pivot table in Excel. Real-time Malaysia SARS-CoV-2 Genomics Surveillance 151 
updates were monitored via (https://bit.ly/2UEFFGt). 152 
The first virus from each lineage with D614G mutation in Spike protein was 153 
extracted using patient’s status metadata downloaded from GISAID until July this 154 
year. To do this, 1356 viruses were analysed manually using Pivot table and the date 155 
was filtered to months and year in Excel. The lineage description was classified 156 
according to the PANGO Lineage List (https://cov-lineages.org/lineage_list.html). 157 
 158 
Phylogenetic tree analysis   159 
 160 
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A total of 1005 complete whole genome sequences of Malaysian variant with 161 
D614G mutation were retrieved from GISAID database (S1 Table 1). A complete 162 
genome of Wuhan-Hu-1 (NC_045512) was downloaded from GenBank 163 
(https://www.ncbi.nlm.nih.gov/sars-cov-2/) for outgroup. The multiple sequence 164 
alignment was performed using DECIPHER [26] and SeqinR [27] packages in R 165 
version 4.0.2 and finalized using MEGA X 11 [28].   166 
Evolutionary analyses conducted in MEGA X was inferred using the Neighbor-167 
Joining (NJ) method [29]. The bootstrap consensus tree inferred from 500 replicates 168 
was taken to represent the evolutionary history of the taxa analyzed. Branches 169 
corresponding to partitions reproduced in less than 50% bootstrap replicates were 170 
collapsed. The evolutionary distances were computed using the Kimura 2-parameter 171 
method and are in the units of the number of base substitutions per site. The rate 172 
variation among sites was modelled with a gamma distribution (shape parameter = 173 
1). All ambiguous positions were removed for each sequence pair (pairwise deletion 174 
option).  175 
 176 
Mutation analysis via computational prediction tools 177 
 178 
Mutation analysis were analyzed using Nextclade v.1.5.2, a web-based 179 
analysis server (https://clades.nextstrain.org) by comparing against a wild-type of 180 
Wuhan-Hu-1 (NC_045512.2).  181 
To evaluate the effect of mutations on protein-protein binding affinity, a 3D 182 
structure model of wild-type Spike protein (YP_009724390.1) was first generated 183 
using SWISS-model based on the most fitted protein template PDB ID: 6XR8 184 
(Distinct conformational states of SARS-CoV-2 spike protein. This 3D structure 185 
model however covers a residue of 14-1162 only. For analyzing the effect of amino 186 
acid substitution in TM domain, a 3D structure PDB ID: 7LC8 (SARS-CoV-2 Spike 187 
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protein TM domain) was used. Both 3D structure model of YP_009724390.1 and 188 
7LC8 were uploaded to mCSM-PPI2 server [30]. Next, the potential pathogenicity 189 
effect of the amino acid substitution on TM domain biological function was 190 
investigated by uploading a 3D structure of TM domain PDB ID: 7LC8  and TM 191 
domain amino acid sequence onto mCSM-membrane [31] and uploading TM amino 192 
acid sequence onto Protein Variation Effect Analyzer (PROVEAN) [32] and SNAP 2 193 
tools  [33]; the web-based  servers for predicting the effect of mutations on the 194 
biological function of a protein. The servers predicted the consequence of amino acid 195 
mutation to be whether benign or pathogenic, deleterious or neutral, effect or neutral, 196 
respectively.  197 
 198 
Statistical analysis 199 
 200 
Data are presented as count and percentage. Chi-square test were carried 201 
out using IBM SPSS v25.0 to testing the statistical significance association of 202 
gender, patient status and age groups with Malaysian lineages. All level of 203 
significances were set at p < 0.05. 204 
 205 
Results 206 
The evolution of D614G variant of SARS-CoV-2 in the 207 
Malaysian population 208 
Of the1,502 SARS-CoV-19 complete genomes deposited to GISAID 209 
database, 1,356 contained Spike D614G mutation in their genomes. To better 210 
characterize the local distribution of lineages that may contribute to the constant 211 
increase in COVID-19 cases in Malaysia, Fig. 1 summarizes the distribution of the 212 
D614G variant lineages throughout the country since it was first detected. Based on 213 
the GISAID database analysis, there were 41 lineages of D614G variant dispersed 214 
 . CC-BY-NC-ND 4.0 International licenseIt is made available under a 
 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)
The copyright holder for this preprint this version posted August 18, 2021. ; https://doi.org/10.1101/2021.08.11.21261902doi: medRxiv preprint 
throughout Malaysia. Lineage B.1.524 (n= 419) and AU. 2 (n=311) appears to have 215 
caused significant transmission of the virus locally compared to Variant of Concern 216 
(VOC) Alpha B.1.1.7 (n=11), Beta B.1.351(n=161), B.1.351.3 (n=2), and Delta 217 
B.1.617.2 (n=58); Variant of Interest (VOI) Eta B.1.525(n=3), Kappa B.1.617.1(n=3), 218 
as well as  lineages currently designated alerts for further monitoring, such as P.2 219 
(n=1), P.3 (n=10), B.1.466.2 (n=70), B.1.214.2 (n=1). 220 
Next, we investigated the frequency of D614G variant clades circulating in 221 
Malaysia until July this year. It appeared that of the six D614G variant clades (GH, 222 
G, GR, GRY, O and GV), GH makes up the largest clade with 760 of genomes from 223 
different lineages (Fig. 1B). Further analysis of Clade GH shows lineage AU.2 had 224 
appeared most often in the transmission of the disease (Fig. 1C) followed by clade 225 
G, in which lineage B.1.524 seems to be the highest contributor in the local 226 
transmission of Covid19 (Fig. 1D).   227 
Our findings on genomic surveillance in depicting local transmission and 228 
evolution of the D61G variant revealed that two of the variants had emerged locally: 229 
B.1.524, and AU.2. Of these two, B.1.524 had silently caused the largest local 230 
transmission of the D614G variant in Malaysia (n= 419), followed by AU.2 (n=311).  231 
Furthermore, splitting the genomes analysis based on years, we found a clear 232 
pattern of lineage distribution which demonstrates how the major lineages disperse 233 
throughout Malaysia in 2020 and 2021 (S1 Fig 1). While the B.1.524 may have 234 
contributed heavily to the initial number of D614G lineage actively spreading locally, 235 
data suggest the AU.2 lineage, is currently taking its place as the major D614G 236 
variant contributor in spreading the disease. This raised a question of where these 237 
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Malaysia lineages originated from. Based on our current analysis, we suggest that 238 
AU.2 might have originated from Sarawak, while B.1.524 remains unknown.  239 
Next we analysed the association of gender, patient status and age group 240 
with Malaysian lineages B.1.524 and AU.2. According to Table 1, there is significant 241 
association in lineage between the gender and age group. The association lineage 242 
between males and females shows significant association (62.10% vs 54.50%, p = 243 
0.049). It is also observed there is significant association between lineage and age 244 
groups (49.10% vs 59.30% vs 45.60%, p = 0.038). However, there is no significant 245 
association between lineage and patient’s status in term of disease severity. 246 
Origin of the massive spread of COVID-19 cases in Pahang  247 
 248 
To infer the origin of the D614G variant that was responsible in  causing  249 
widespread COVID-19 infections in Pahang this year, we built a NJ phylogenetic tree 250 
using D614G variant complete genomes downloaded from GISAID (Fig. 2). The virus 251 
sample collection dates restricted to January 1, 2021 until July this year (n=1005). 252 
Based on our analysis, there were 22 SARS-CoV-2 lineages actively dispersed in 253 
Malaysia this year. NJ phylogenetic analysis constructed in Fig. 2A demonstrated 254 
that despite being identified  as Malaysian lineages, both AU. 2 and B.1.524 were 255 
distantly diverged from each other.  256 
In order to generate comprehensive  phylogenetic analyses of the D614G 257 
variant actively spreading in Pahang, a closed up view of the evolutionary tree 258 
constructed in Fig. 2A was visualized in Fig. 2B-2D. A closed up view of the NJ 259 
phylogenetic tree shown in Fig. 2B is focused on IIUM5763/2021, clustered to 260 
B.1.462 (Indonesian lineage). While Fig. 2C highlighted a phylogenetic tree analysis 261 
of IIUM6472/2021, UMP-IIUM5437, UMP-IIUM5480, IIUM5556/2021, 262 
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IIUM5754/2021, IIUM5755/2021, IIUM5770/2021, clustered to Beta B.1.351. And 263 
Fig. 2D visualized the result of evolutionary analysis of IIUM5371/2021and 264 
IIUM5676, clustered to B.1.524 (Malaysian lineage). Further analysis of Fig. 2B 265 
suggested that IIUM 5763/2021 was closely related to sample MGI DNALAB-266 
DM210401060/2021, which originated in Selangor, including IMR WC243006/2021 267 
and IMR 033590. 268 
IIUM 5770/2021. IIUM 5755/2021 and IIUM 5754/2021 shown in Fig. 2C were 269 
strongly related to one another as the viruses were sampled from patients who had 270 
travelling history from similar place. Remarkably, these three genomes demonstrated 271 
distant correlations with other virus genomes deposited in the GISAID database. 272 
Comparison of genomes IIUM 5556/2021 and UMP-IIUM 5437/2021 show highest 273 
similarity to each other, and are closely related to UMP-IIUM 5480/2021. 274 
Nevertheless, these three genomes were distantly diverged to IIUM 6472/2021  275 
although they share the same initial internal node on the NJ tree. Our analysis 276 
demonstrated that IIUM 6472/2021 was closely related to IMR_WC268879/2021, 277 
which was sampled locally. 278 
Referring to Fig. 2D, UMP 5371/2021 was distantly diverged to IIUM 279 
5676/2021 with different internal nodes. It appears that IIUM 5676/2021 was closely 280 
related to IMR WC65476/2021 sampled from an unspecified location in Malaysia. 281 
UMP5371/2021 was found to be closely related to IMR BT86174.  282 
Mutations in Spike protein of Malaysian lineages 283 
419 complete genomes of B.1.524 and 311 complete genomes of AU.2 were 284 
uploaded to Nextclade v.1.5.2 (https://clades.nextstrain.org) to analyse dominant 285 
mutations occur in Spike protein of Malaysian lineages. Based on our analysis 286 
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presented in Fig. 3, other than D614G mutation, B.1.524 carries A701V mutation in 287 
Spike protein. Whereas, AU.2 carries a mutation at positions 439 from Asparagine 288 
(N) to Lysine (K), 681 from Proline (P) to Arginine(R) and 1251 from Glycine (G) to 289 
Valine (V). 290 
Amino acid mutations in Spike protein of the Pahang- 291 
D614G variant SARS-CoV-2 292 
1005 complete genomes of the D614G variant were analysed for sequence 293 
quality and mutation. Of that, 986 complete genomes passed Nextclade’s sequence 294 
quality control. Focusing on mutation in the Spike protein, our analysis revealed that 295 
all of Pahang’s SARS-CoV-2 isolates had a unique substitution mutation of Glycine 296 
(G) to Cysteine (C) at position 1223  (G1223C) which was not found in the other 976 297 
genomes (S4 Fig. 2). A list of amino acid mutations in Spike protein of Pahang’s 298 
G614 variant were summarized in Fig. 4. 299 
The effects of single-point mutations on protein-protein interaction binding 300 
affinity was performed using mCSM-PPI2. The result of the analysis was 301 
summarized in Table 2. To do this, a 3D structural model of wild type Spike protein 302 
(YP_0097243901) was first generated through SWISS MODEL using a protein 303 
template model of 6XR8 (distinct conformation states of SARS-CoV-2 Spike protein). 304 
The 3D structure model of YP_0097243901 generated only covered residues 14 to 305 
1162. As such, prediction of the effects of missence mutation on protein-protein 306 
interaction binding affinity only covered residues within this region. Of note, mCSM-307 
PPI2 is unable to predict the change in protein interaction affinity in single amino acid 308 
deletions, hence analysis on L241del, L242del and A243del were not included in 309 
Table 2. To analyse the effects of G1223C mutation in the TM region of Spike 310 
protein, a 3D structure model of the SARS-CoV-2 Spike protein TM domain 7LC8 311 
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downloaded from RCSB Protein Data Bank was directly uploaded to the mCSM-312 
PPI2 server. The effects of G1223C mutation in the TM domain was included in 313 
Table 2. Together, the missence mutations L18F, N501Y, A701V and G1223C 314 
seems to have increased the binding affinity of the Spike protein, while mutations 315 
D80A, D215G, K417N, N439K, E484K and A688S had the opposite effect. Focusing 316 
on the unique mutation G1223C, the difference in intramolecular interactions 317 
between the wild type G1223 and the mutant C1223 shown in Fig. 3, suggests that 318 
G1223C does not cause significant  structural rearrangement of the TM domain, 319 
except for the gain in salt bridge between  C1223 and G1219 (Fig. 5 - Mutant 320 
(C1223)).  321 
Subsequently, further analysis on the effects of all missense mutations 322 
occurring at the 1223 residue on the TM domain functionality was performed using 323 
SNAP2, PROVEAN and mCSM-membrane was summarized in Table 3. Overall, two 324 
computational prediction tools, PROVEAN and SNAP2 suggesting for a possibly 325 
serious evolutionary damaging consequence of protein biological function due to 326 
G1223C mutation in TM domain.  327 
 328 
Discussion 329 
  330 
The first incidence of COVID-19 in Malaysia was discovered  on January of 331 
2020 and was traced back to be originated from China [34]. The local Malaysian 332 
authority quickly developed standard guidelines for the management of COVID-19, 333 
including the set-up of designated hospitals and screening centers in each state [34]. 334 
To date, more than 951,884 COVID-19 cases was recorded, with increasing 335 
fatalities. Based on earlier report, we found that D614G mutation sample had been 336 
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circulating in Pahang [24] and subsequently found elsewhere throughout Malaysia as 337 
the infection continues. For the record,  the earliest study on SARS-CoV-2 virus 338 
genomes in Malaysia did not found D614G mutation, even the lineage B.6 that 339 
caused major outbreak for the second wave in Malaysia indicated with no D614G 340 
mutation in Spike protein [35]. 341 
Although major concerns have been raised  on the emergence of Beta 342 
B.1.351 (VOC African lineage) and Delta B.1.617.2 (VOC Indian lineage) for their  343 
capability to cause  severe infection and fatality, our detailed analysis of SARS-CoV-344 
2 genomes from the Malaysian population reported two lineages of D614G variant 345 
that are actively dispersed locally. To our knowledge, the emergence of lineage 346 
B.1.524 was first detected on September last year.  The analysis from early 2021 347 
suggests that AU.2 had become dominant lineage that actively spread in Malaysia 348 
for 2021 followed by B.1.524. We observed that AU.2 had closest distance branch to 349 
B.1.4662 (Indonesian lineage), as both lineages carry the same amino acid 350 
mutations at N439K in RBD region and P681R in non RBD region of Spike protein. 351 
Its presence in Malaysia could be due to transference of the disease via visitors from 352 
Indonesia. Our detail analysis also suggests, AU.2 is not correlated to B.1.524. as 353 
B.1.524 harbours different mutations in Spike protein; A701V. Moreover, lineages 354 
assignment using pangolin (v2.1.6, https://github.com/cov-lineages/pangolin) 355 
described AU.2 and B.1.524 as Malaysia 94.0%, Indonesia 5.0%, United States of 356 
America 0.0%, India 0.0%, Singapore 0.0%, and Malaysia 76.0%, Singapore 16.0%, 357 
Thailand 3.0%, Philippines 2.0%, India 1.0%, respectively.  358 
Of the 41 lineages of D614G variants detected in Malaysia, 19 lineages have 359 
disappeared, leaving 22 lineages still actively spreading into 2021. When a virus 360 
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mutates, it undergoes alterations that may result in the development of new isolates 361 
following replication. Non-synonymous substitutions are extremely important since 362 
they result in an amino acid change, which in turn induces structural change [36]. 363 
This will later cause functional instability in isolates, resulting in susceptible illnesses, 364 
and even an increase in the degree of pathogenicity [36]. In nations with poor 365 
containment capability, it was proven that the SARS-CoV-2 mutant lineage G (S-366 
D614G) was able to replace earlier lineages more efficiently and was associated with 367 
a higher degree of disease severity [37]. Moreover, the emergence of more virulent 368 
strains such as VOC and VOI that harbored the D614G mutation in Spike protein 369 
suggests that D614G variant had constantly subjected to positive selection pressure. 370 
Consequently, combination of various mutations in Spike protein had increased viral  371 
transmission [38–40], increased severity based on hospitalization cases and fatality 372 
rates [41], reduced susceptibility to the monoclonal antibody treatment [42]  and 373 
reduced neutralization by convalescent and post vaccination sera [43–47].  374 
Even though recent study suggested that the GR was a predominant clade in 375 
Asia [48], our study found that GH is the major infecting clade in Malaysia, follows by 376 
G. To the best of our knowledge, study related to AU.2 lineage in relating to disease 377 
epidemiology and pathology is scarce, however, the VOC of African B.1.351 that 378 
grouped together with AU.2 clade, was reported to significantly correlated with high 379 
disease severity and mortality [48]. Majority of mutations observed in this are 380 
deleterious in nature, unstable with impaired biological functions [49]. Based on 381 
these reasons, we anticipated that this may cause of high-risk transmission in 382 
Malaysia. On the other hand, the Malaysian lineage of B.1.524 is assigned to clade 383 
G that commonly associated with mild symptoms or asymptomatic cases [48]. 384 
Moreover, other study reported that the infection with clade G was not related with 385 
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disease severity, and there was no clear indication of enhanced transmissibility 386 
despite greater viral loads [50].  387 
We further analyzed the SARS-COV-2 genomes based on stratification of 388 
gender, age groups and disease’s status that available from the GISAID. Our 389 
metadata analysis showed higher (p < 0.05) prevalence among male patient with 390 
B.1.524 (G clade) variants. We postulate that male population are more vulnerable 391 
and susceptible to B.1.524 variant and a large-scale data is needed to understand 392 
further regarding this matter. Previous study showed that men with COVID-19 are 393 
more at risk for worse outcomes and mortality regardless of age [51] due to 394 
fundamental differences in the immune response between males and females 395 
despite socio-economic factors [52]. The disease distribution is significantly higher 396 
among adolescent and adult age group in both AU.2 and B.1.524 group (p < 0.05). 397 
This could be explained due to presence of comorbidities, immunological 398 
senescence and changes in ACE2 receptors [48]. However, our study showed 399 
negative correlation between both lineages in relation to disease severity. Here, we 400 
anticipate that this may be due to lack data related to the disease severity among 401 
Malaysian patients in GISAID. 402 
Higher infectivity of the SARS-CoV-2 is associated with increased in binding 403 
affinity between Spike protein and ACE2 due to K417N, E484K, N439K and N501Y 404 
mutations in the RBD of Spike protein. While N501Y mutation alone enhanced Spike 405 
RBD-ACE2 affinity[53], combination of K417N, E484K and N501Y  mutations in 406 
B.1.351 African lineage resulted in the highest degree of conformational alterations 407 
of RBD when bound to ACE2 [54–56]. Although N439K mutation in RBD was first 408 
found in already extinct lineage B.1.1.41 (also known as Engligh lineage), a new 409 
lineage B.1.258 (also known as UK lineage) independently acquired N439K[57]. 410 
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While it is unknown whether B.1.466.2 (also known as Indonesian lineage) acquired 411 
N439K independently, AU.2 of Malaysian lineage is resembling to this lineage. Of 412 
concern, N439K mutation promotes evasion of antibody-mediated immunity by 413 
conferring resistance against several neutralizing monoclonal antibodies and 414 
reduces the activity of some polyclonal sera from patients recovered from infection 415 
[58]. However, there is no evidence of change in disease severity in a large cohort of 416 
patients infected with N439K virus [58].  417 
In addition, A701V mutation at adjacent to the furin cleavage site of Spike 418 
protein subunit S1 and S2 in B.1.524 of Malaysian lineage was also occurs in 419 
B.1.351, and several variants under monitoring such as B.1.351+P384L (African), 420 
B.1.351+E516Q (Unclear) and Iota B.1.526 (USA) [59]. Although our computational 421 
prediction effect of A701V mutation suggest increase in protein-protein binding 422 
affinity, there is none functional experiment as we concern had been run to 423 
determine possible effect of A701V on virus transmissibility, immunity or infection 424 
severity. While A701V is still of unknown significance, further study should be 425 
performed accordingly.  426 
In tracking the distribution of the ten lineages which caused blooming of 427 
positive COVID-19 cases in Pahang this year, it appears that all virus collected from 428 
Pahang have the same substitution of amino acid at 1233 from Glycine to Cysteine 429 
that related to mutation in TM domain of Spike protein that not common in Malaysia. 430 
Of interest, G1223C mutation had been found in England (13), Michigan (8), 431 
Stockholm (2), Portugal (1) and Germany (1) [60]. While the significance of G1223C 432 
mutation is still unknown, it is well known that Spike protein mediates entry of SARS-433 
CoV-2 into target cells through two steps. First, it involves binding of RBD to its 434 
receptor human ACE2 and is proteolytically activated by human proteases at the 435 
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S1/S2 boundary. Second, it follows by S2 of which include TM domain will 436 
undergoes structural change to mediate viral membrane fusion with targeted cells 437 
[61,62]. To date, very little attention was put on the TM domain in the requirements 438 
for SARS-CoV cell entry. Although sequence analysis on TM domain among all 439 
coronaviruses Spike protein conducted previously [61,63] revealed a high 440 
conservation rate, extensive mutation in TM domain of SARS-CoV however caused 441 
incapability of the virus to establish complete membrane fusion process [61]. Highly 442 
conserved small amino acids in TM domain of SARS-CoV-2 Spike protein (G1219, 443 
A1222, G1223, A1226) which initially thought to be important for TM domain 444 
oligomerization, but latest finding [63] showed neither glycine nor alanine in the 445 
trimer structure appear to be important for hydrophobic core formation. Thus, 446 
suggesting a possible role of the glycine motif is in a later step of fusion. We believe 447 
the effect of G1223C mutation in TM domain deserve to further analyze in future 448 
functional experiments for addressing above question.   449 
This study has some limitations. First, the work on WGS in characterizing the 450 
circulating variants in Malaysia needed to be underscored systematically by 451 
representing Malaysian cases. Therefore, in order to success in combating the 452 
spread of COVID-19 in Malaysia, utilizing a viral genomics sequencing is critical to 453 
be used as a key tool for understanding the spread of COVID-19. By integrating viral 454 
genomics with epidemiological and modelling data, local transmission chains and 455 
regional spread were able to be tracked and audited in real time [64]. This strategy 456 
was proven to curb the spread of COVID-19 in a developed country for example 457 
Australia [65] and New Zealand [64]. Second, lack of patient clinical status details 458 
deposited to GISAID database hampered the analysis of the impact of the 459 
distribution of each individual clades on the disease epidemiology locally. Therefore, 460 
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specifying whether the virus samples were collected from asymptomatic or mild 461 
symptoms, to severe or deceased might help to identify the prevalence of each 462 
major clade and lineage frequently detected. We also discovered a plethora of 463 
unclear entries that offer very little information about the real source of a sample. All 464 
of these issues can affect the effectiveness and accuracy of association studies. We 465 
therefore advocate for SARS-CoV-2 genomic data providers to comprehensively 466 
when submitting metadata, and encourage genomic database maintainers to be 467 
aware of potential errors in incoming samples and to actively support metadata 468 
standards.  One option  may be to entirely disregard samples with suspected 469 
metadata issues,  however this may  result in considerable reduction of sample size, 470 




Here, we reported the most prevalent SARS-CoV-2 lineages of B.1.524 and 475 
AU.2 that sustained major outbreak of COVID-19 transmission during third wave of 476 
infection in Malaysia. Whereby the mutation at G1223C is under reported and further 477 
functional experiment is warranted. Furthermore, the N439K mutation that observed 478 
in RBD of AU.2 is deserved for comprehensive attention and monitoring due to its 479 
capability to increase virus infectivity while evading antibody-mediated immunity. 480 
Uncontrolled, and intensive virus transmission will result in the development of 481 
additional virus mutations, which may have significant influence on vaccination 482 
efficacy and perhaps, disease severity. The continual emergence of novel SARS-483 
COV-2 variations highlights the need for public compliance with SOPs and other 484 
recommendations, notably mask use, hand cleanliness and physical separation, as 485 
well as the necessity to acquire herd immunity through the vaccination program. 486 
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These measures will aid in slowing viral transmission and reducing the likelihood of 487 
new variations emerging in the population. 488 
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List of figures 728 
Fig. 1. D614G variant lineage and clade distributions in Malaysia. A. Distribution 729 
of lineages of D614G variant based on all complete genomes from Malaysia 730 
deposited in GISAID until July 5, 2021 (n=1356). B. D614G variant clade distribution 731 
based on all complete genomes from Malaysia deposited in GISAID until July 19, 732 
2021. (n=1356) C. Lineage clustered to clade GH. D. Lineage clustered to clade G.  733 
 734 
Fig. 2. Phylogenetic tree of 1005 complete genomes of Malaysia D614G variant 735 
in 2021. A. The evolutionary history was inferred using the Neighbor Joining (NJ) 736 
method with 500 bootstrap replications. Branches corresponding to partitions 737 
reproduced in less than 50% bootstrap replicates are collapsed. The percentage of 738 
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replicate trees in which the associated taxa clustered together in the bootstrap test 739 
(500 replicates) are shown next to the branches. The evolutionary distances were 740 
computed using the Kimura 2-parameter method and the rate variation among sites 741 
was modeled with a gamma distribution (shape parameter = 1). This analysis 742 
involved 1005 nucleotide sequences. Codon positions included were 743 
1st+2nd+3rd+Noncoding. All ambiguous positions were removed for each sequence 744 
pair (pairwise deletion option). There was a total of 29672 positions in the final 745 
dataset. Evolutionary analyses were conducted in MEGA X. B. A closed-up view of 746 
NJ phylogenetic tree focusing on Pahang D614G variant of IIUM 5763/2021, from 747 
lineage B.1.466.2. C. A closed-up view of NJ phylogenetic tree focusing on Pahang 748 
D614G variant of IIUM5754/2021, IIUM5770/2021, IIUM5755/2021, IIUM-749 
UMP5480/2021, IIUM-UMP5437/2021, IIUM5556/2021 and IIUM6472/2021, from 750 
lineage B.1.351. D. A closed-up view of NJ Phylogenetic tree focusing on Pahang 751 
D614G variant of UMP5371/2021 and IIUM5676/2021, from lineage B.1.524.  752 
 753 
Fig. 3: List of mutations in Spike protein of Malaysian lineages. A.  B.1.524 754 
carries a mutation of D614G and A701V. B. AU.2 carries a mutation of N439K, 755 
D614G, P681R and G1251V. A screen shot images presented here represent some 756 
of genomes analysed using Nexclade v.1.5.2  (https://clades.nextstrain.org).  757 
 758 
Fig. 4: Point of mutations in Spike protein of Pahang SARS-CoV-2, D614G 759 
variant with a schematic representation of the SARS-CoV-2 Spike shown at the 760 
bottom. The listed domain boundaries was defined according to recently published 761 
source. NTD: N-terminal domain; RBD: receptor-binding domain; :S1/S2 cleavage 762 
site; FP: fusion peptide; HR1:heptad repeat 1; HR2: heptad repeat 2; TM: 763 
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transmembrane domain; CD: connector domain. An amino acid mutation was 764 
analysed using Nexclade v.1.5.2  (https://clades.nextstrain.org).  765 
 766 
Fig 5. Interatomic interaction in TM domain of wild-type (G1223) compared to 767 
mutant (C1223). The surrounding residues with close interaction with the wild-type 768 
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Table 1. The distribution of the lineage between gender, patient status and age 777 
groups. 778 
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Table 2. The effect of missenses mutation in Spike protein of Pahang D614G 793 
SAR-CoV-2 as predicted by mCSM-PPI2.  794 
Lineage, n (%) Total, n (%) c
2
p value
AU.2 (GH) B.1.524 (G)
Gender Male 134(37.9) 220(62.1) 354(100) 3.862 0.049
Female 132(45.5) 158(54.5) 290(100)
Patient 
Status
Deceased 0 3(100) 3(100) 1.541 0.463
Hospitalized 0 6(100) 6(100)
Live 36(14.7) 209(85.3) 245(100)
Age 
Groups
0-14 years 27(50.9) 26(49.1) 53(100) 6.542 0.038
15-64 years 190(40.7) 277(59.3) 467(100)
>64 years 43(54.4) 36(45.6) 79(100)
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LEU(L) 18 PHE(F) 25.747 0.85 Increasing
ASP(D) 80 ALA(A) 24.602 -0.181 Decreasing
ASP(D) 215 GLY(G) 23.94 -0.178 Decreasing
LYS(K) 417 ASN(N) 3.107 -1.628 Decreasing
ASN(N) 439 LYS(K) 7.043 -0.319 Decreasing
GLU(E) 484 LYS(K) 13.698 -0.454 Decreasing
ASN(N) 501 TYR(Y) 7.588 0.16 Increasing
ALA(A) 688 SER(S) 26.327 -0.044 Decreasing
ALA(A) 701 TYR(V) 2.737 0.922 Increasing
GLY(G) 1223 CYS(C) 5.489 0.233 Increasing
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  811 
Legends: Computational prediction was performed by using three web-based tools:  812 
     mCSM-membrane http://biosig.unimelb.edu.au/mcsm_membrane/  813 
     PROVEAN  http://provean.jcvi.org/seq_submit.php 814 
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Fig. 1. D614G variant lineage and clade distributions in Malaysia A. Distribution 
of lineages of D614G variant based on all complete genomes from Malaysia deposited 
in GISAID until July 5, 2021 (n=1356). B. D614G variant clade distribution based on 
all complete genomes from Malaysia deposited in GISAID until July 19, 2021 (n=1356) 









D614G variant clade distribution in Malaysia 
G GH GR GRY GV O
C.
D.
D614G variant lineage distribution in Malaysia from March,2020 to July,2021
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A. B. B.1.466.2 (Indonesian lineage)
C.  B.1.351 (VOC African lineage) D.  B.1.524 (Malaysian lineage)
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Fig. 2. Phylogenetic tree of 1005 complete genomes of Malaysia D614G variant 
in 2021. A. The evolutionary history was inferred using the Neighbor Joining (NJ) 
method with 500 bootstrap replications. Branches corresponding to partitions 
reproduced in less than 50% bootstrap replicates are collapsed. The percentage of 
replicate trees in which the associated taxa clustered together in the bootstrap test 
(500 replicates) are shown next to the branches. The evolutionary distances were 
computed using the Kimura 2-parameter method and the rate variation among sites 
was modeled with a gamma distribution (shape parameter = 1). This analysis involved 
1006 nucleotide sequences. Codon positions included were 1st+2nd+3rd+Noncoding. 
All ambiguous positions were removed for each sequence pair (pairwise deletion 
option). There was a total of 29672 positions in the final dataset. Evolutionary analyses 
were conducted in MEGA X. B. A closed-up view of NJ phylogenetic tree focusing on 
Pahang D614G variant of IIUM 5763/2021, from lineage B.1.466.2. C. A closed-up 
view of NJ phylogenetic tree focusing on Pahang D614G variant of IIUM5754/2021, 
IIUM5770/2021, IIUM5755/2021, IIUM-UMP5480/2021, IIUM- UMP5437/2021, 
IIUM5556/2021 and IIUM6472/2021, from lineage B.1.351. D. A closed-up view of NJ 
Phylogenetic tree focusing on Pahang D614G variant of UMP5371/2021 and 
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Fig. 3: List of mutations in Spike protein of Malaysian lineages. A.  B.1.524 carries 
a mutation of D614G and A701V. B. AU.2 carries a mutation of N439K, D614G, P681R 
and G1251V. A screen shot images presented here represent some of genomes 
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Fig. 4: Point of mutations in Spike protein of Pahang SARS-CoV-2,D614G variant 
with a schematic representation of the SARS-CoV-2 Spike shown at the bottom. 
The listed domain boundaries was defined according to recently published source. 
NTD: N-terminal domain; RBD: receptor-binding domain;  :S1/S2 cleavage site; FP: 
fusion peptide; HR1:heptad repeat 1; HR2: heptad repeat 2; TM: transmembrane 
domain; CD: connector domain. An amino acid mutation was analysed using Nexclade 
v.1.5.2  (https://clades.nextstrain.org).  
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Fig 5. Interatomic interaction in TM domain of wild-type (G1223) compared to 
mutant (C1223). The surrounding residues with close interaction with the wild-type 
and mutant residue of 1223 are highlighted. 
 
Wild-type G1223 Mutant C1223
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